Please login to the form below

Not currently logged in
Email:
Password:

ABPI revises UK Code Of Practice

The Association of British the Pharmaceutical Industry has revealed it will revise its Code of Practice, following the publication of a European-wide code on relationships between the pharmaceutical industry and patient organisations.

The Association of British the Pharmaceutical Industry (ABPI) has revealed it will revise its Code of Practice, following the publication of a European-wide code on relationships between the pharmaceutical industry and patient organisations.

The ABPI code oversees the activities of UK-based pharmaceutical companies and their employees. It is also required to include all the provisions of the code administered by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

The ABPI and other national trade associations in Europe have been cooperating with EFPIA to develop and draft the new code. Most of the new provisions are already covered by the existing ABPI code, but those covering aspects of companies' relationships with patient organisations, must incorporate the new EFPIA rules.

The deadline for the implementation of the new changes is 1 July 2008. For example, companies will now have to include a short description of the nature of the support provided to patient organisations. Also, indirect financial backing and indirect, non-financial support will also need to be declared.

Nigel Brooksby, President of the ABPI, said: "Our code is one of the most rigorous in the world, and it is reviewed every two to three years to ensure that it remains fit for purpose. As well as taking on board the comparatively small number of changes that the new European patient code makes necessary, we shall be looking at including any suggested alterations identified during the life of the current code."

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics